13F Pro13F Pro

SECTOR GAMMA AS

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1475373
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare97.9%$451.3M
  • Consumer Staples2.1%$9.7M

AUM History

13fpro.ai/research/fund/sector-gamma-as-1475373

Conviction and streaks

Diversifying · top 10 = 48.4%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

BMY$BMYConviction hold9.1% weight · held 10 quartersMRK$MRKConviction hold6.0% weight · held 5 quartersMDT$MDTConviction hold6.0% weight · held 10 quartersPFE$PFEConviction hold5.3% weight · held 10 quartersINCY$INCYConviction hold4.2% weight · held 10 quartersGEHC$GEHCAccumulating+316% shares · 6 quarters runningBMRN$BMRNAccumulating+141% shares · 4 quarters runningELV$ELVAccumulating+363% shares · 3 quarters runningMDT$MDTAccumulating+31% shares · 2 quarters runningTMO$TMOAccumulating+82% shares · 2 quarters runningAMGN$AMGNTrimming-57% shares · 3 quarters runningMRK$MRKTrimming-40% shares · 2 quarters runningINCY$INCYTrimming-22% shares · 2 quarters runningCAH$CAHTrimming-34% shares · 2 quarters runningBRKR$BRKRTrimming-40% shares · 2 quarters running

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/sector-gamma-as-1475373

SECTOR GAMMA AS 13F holdings — Q2 2026

$461.0M portfolio (+8.8% QoQ) · 40 holdings · Q2 2026 13F · top 10 are 48% of the stock portfolio

All holdings — SECTOR GAMMA AS (Q2 2026)

40 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
IONS$IONSIONIS PHARMACEUTICALS INC$15.0M+12%
BDX$BDXBECTON DICKINSON & CO$14.1M+13%
ABT$ABTABBOTT LABORATORIES$13.4M+68%
GEHC$GEHCGE HealthCare Technologies Inc.$13.3M+64%
ZBH$ZBHZIMMER BIOMET HOLDINGS, INC.$12.3M-9%
BIIB$BIIBBIOGEN INC.$11.7M-40%
QGEN$QGENQIAGEN N.V.$11.2M+77%
CNC$CNCCENTENE CORP$10.4M—
REGN$REGNREGENERON PHARMACEUTICALS, INC.$9.8MNew
BIO$BIOBIO-RAD LABORATORIES, INC.$9.8M+40%
CAH$CAHCARDINAL HEALTH INC$9.7M-26%
AMGN$AMGNAMGEN INC$9.5M-44%
BRKR$BRKRBRUKER CORP$9.2M-40%
AVTR$AVTRAvantor, Inc.$9.0M+30%
PTCT$PTCTPTC THERAPEUTICS, INC.$8.2M+33%

What changed in Q2 2026

Against the previous quarter's 13F: 6 new, 19 added to, 11 trimmed, 8 sold out. Share-count changes; largest moves by dollar size first.

New positions (6)

  • TMO$TMOTHERMO FISHER SCIENTIFIC INC.$16.8M

    first bought this quarter

  • REGN$REGNREGENERON PHARMACEUTICALS, INC.$9.8M

    first bought this quarter

  • BSX$BSXBOSTON SCIENTIFIC CORP$5.2M

    first bought this quarter

  • TVTX$TVTXTravere Therapeutics, Inc.$4.5M

    first bought this quarter

  • CYTK$CYTKCYTOKINETICS INC$3.8M

    first bought this quarter

  • NTLA$NTLAIntellia Therapeutics, Inc.$3.1M

    first bought this quarter

Added to (19)

  • IQV$IQVIQVIA HOLDINGS INC.+94%

    now $15.1M · held 2 qtrs, 2 adds in a row

  • MDT$MDTMedtronic plc+26%

    now $27.6M · held 5+ qtrs, 2 adds in a row

  • ABT$ABTABBOTT LABORATORIES+68%

    now $13.4M · held 2 qtrs, 2 adds in a row

  • GEHC$GEHCGE HealthCare Technologies Inc.+64%

    now $13.3M · held 5+ qtrs, 4 adds in a row

  • QGEN$QGENQIAGEN N.V.+77%

    now $11.2M · held 2 qtrs, 2 adds in a row

  • BMRN$BMRNBIOMARIN PHARMACEUTICAL INC+23%

    now $16.9M · held 5+ qtrs, 4 adds in a row

+13 more in the Excel export

Trimmed (11)

  • BIIB$BIIBBIOGEN INC.-40%

    now $11.7M · held 5+ qtrs

  • AMGN$AMGNAMGEN INC-44%

    now $9.5M · held 5+ qtrs, 2 trims in a row

  • BRKR$BRKRBRUKER CORP-40%

    now $9.2M · held 5+ qtrs

  • BMY$BMYBRISTOL MYERS SQUIBB CO-12%

    now $41.8M · held 5+ qtrs

  • MRK$MRKMerck & Co., Inc.-17%

    now $27.9M · held 5+ qtrs, 2 trims in a row

  • CAH$CAHCARDINAL HEALTH INC-26%

    now $9.7M · held 5+ qtrs, 2 trims in a row

+5 more in the Excel export

Sold out (8)

  • UNH$UNHUNITEDHEALTH GROUP INCwas $9.9M

    held 1 qtr

  • GILD$GILDGILEAD SCIENCES, INC.was $7.4M

    held 9+ qtrs

  • LNTH$LNTHLantheus Holdings, Inc.was $7.1M

    held 9+ qtrs

  • HUM$HUMHUMANA INCwas $3.3M

    held 1 qtr

  • BBIO$BBIOBridgeBio Pharma, Inc.was $3.3M
  • DNLI$DNLIDenali Therapeutics Inc.was $3.1M

+2 more in the Excel export

Share

Holdings by quarter

Every 13F SECTOR GAMMA AS has filed, 38 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow SECTOR GAMMA AS?

Q2 2026 13F filed with the SEC on Aug 12, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of SECTOR GAMMA AS's top 20 holdings: 62/100 (our AI quality score, weighted by position size; 19 of the 20 are scored)

Top 10 since filing

+2.4%

Value-weighted move of the 10 largest stock positions

Turnover

19%

Last quarter; 58% over the last 4

Top 10 weight

48%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

79%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q2 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

SECTOR GAMMA AS disclosed 40 positions worth $461.0M in its Form 13F-HR for Q2 2026, led by $BMY (BRISTOL MYERS SQUIBB CO) at 9.1% of the equity portfolio, followed by $MRK and $MDT. During the quarter the fund opened 6 new positions and exited 8 — including a new stake in $TMO and a full exit from $UNH. The portfolio is most concentrated in Healthcare (97.9% of disclosed assets). All figures are sourced directly from SECTOR GAMMA AS’s Form 13F-HR filing with the SEC under CIK 1475373.

Funds like this

managers whose biggest positions overlap SECTOR GAMMA AS's
SOUND SHORE MANAGEMENT INC /CT/$3.25B 13F book · 8 shared top holdingsELVPFEINCYTMODefilade Capital Management, L.P.$746.95M 13F book · 8 shared top holdingsPFEBMRNTMOMDTBellevue Group AG$4.75B 13F book · 10 shared top holdingsAMGNREGNABTMDTIntegral Health Asset Management, LLC$2.53B 13F book · 12 shared top holdingsCVSCAHABTEWVestal Point Capital, LP$4.28B 13F book · 6 shared top holdingsBMRNABTZBHBMYRhenman & Partners Asset Management AB$1.06B 13F book · 10 shared top holdingsCVSBIIBREGNBMRN

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: SECTOR GAMMA AS

13F Pro is an AI hedge fund tracker and stock research platform. For SECTOR GAMMA AS (SEC CIK: 1475373), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in SECTOR GAMMA AS's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.